Nasdaq · USD
KNSA
Sign in to followKiniksa Pharmaceuticals International, plc
Export transactions ↓Last 12 months
Inside the activity.
0 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 12 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 21, 2022 Filed Mar 23, 2022 20:30 UTC |
Paolini John F.CHIEF MEDICAL OFFICER
|
Exercise / conversionClass A Common Share | 5,676 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-003283 · form4-03232022_040310.xml · nonDerivative · entry 1 Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 20:30 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
Exercise / conversionRestricted Share Unit · Derivative | 3,231 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-003285 · form4-03232022_040321.xml · derivative · entry 3 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Share · 3,231 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. F2 · derivative.exercise_date: The performance criteria for these RSUs were met. The RSUs vested in a single installment on March 20, 2022; there was no expiration date for the RSUs. F2 · derivative.expiration_date: The performance criteria for these RSUs were met. The RSUs vested in a single installment on March 20, 2022; there was no expiration date for the RSUs. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 20:30 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
Tax withholdingClass A Common Share | 1,120 | $10.98 | $12,297.60 |
DisclosureSEC source: 0001415889-22-003285 · form4-03232022_040321.xml · nonDerivative · entry 2 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,041 Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 20:30 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
Exercise / conversionClass A Common Share | 3,231 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-003285 · form4-03232022_040321.xml · nonDerivative · entry 1 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 20:30 UTC |
Tessari EbenCHIEF OPERATING OFFICER
|
Exercise / conversionRestricted Share Unit · Derivative | 4,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-003282 · form4-03232022_040302.xml · derivative · entry 3 Tessari Eben · CIK 0001867899 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Share · 4,611 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. F2 · derivative.exercise_date: The performance criteria for these RSUs were met. The RSUs vested in a single installment on March 20, 2022; there was no expiration date for the RSUs. F2 · derivative.expiration_date: The performance criteria for these RSUs were met. The RSUs vested in a single installment on March 20, 2022; there was no expiration date for the RSUs. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 20:30 UTC |
Tessari EbenCHIEF OPERATING OFFICER
|
Tax withholdingClass A Common Share | 1,461 | $10.98 | $16,041.78 |
DisclosureSEC source: 0001415889-22-003282 · form4-03232022_040302.xml · nonDerivative · entry 2 Tessari Eben · CIK 0001867899 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,213 Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 20:30 UTC |
Tessari EbenCHIEF OPERATING OFFICER
|
Exercise / conversionClass A Common Share | 4,611 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-003282 · form4-03232022_040302.xml · nonDerivative · entry 1 Tessari Eben · CIK 0001867899 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:38 UTC |
Ragosa MarkChief Financial Officer
|
Exercise / conversionRestricted Share Unit · Derivative | 872 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002325 · edgar.xml · derivative · entry 3 Ragosa Mark · CIK 0001835458 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,616 Underlying: Class A Common Share · 872 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. F2 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021. F2 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:38 UTC |
Ragosa MarkChief Financial Officer
|
Tax withholdingClass A Common Share | 303 | $10.13 | $3,069.39 |
DisclosureSEC source: 0001179110-22-002325 · edgar.xml · nonDerivative · entry 2 Ragosa Mark · CIK 0001835458 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,676 Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:38 UTC |
Ragosa MarkChief Financial Officer
|
Exercise / conversionClass A Common Share | 872 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-002325 · edgar.xml · nonDerivative · entry 1 Ragosa Mark · CIK 0001835458 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:40 UTC |
Megna Michael RChief Accounting Officer
|
Exercise / conversionRestricted Share Unit · Derivative | 775 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002329 · edgar.xml · derivative · entry 7 Megna Michael R · CIK 0001464583 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,323 Underlying: Class A Common Share · 775 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. F6 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021. F6 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:40 UTC |
Megna Michael RChief Accounting Officer
|
Tax withholdingClass A Common Share | 269 | $10.13 | $2,724.97 |
DisclosureSEC source: 0001179110-22-002329 · edgar.xml · nonDerivative · entry 6 Megna Michael R · CIK 0001464583 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,930 Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:40 UTC |
Megna Michael RChief Accounting Officer
|
Exercise / conversionClass A Common Share | 775 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-002329 · edgar.xml · nonDerivative · entry 5 Megna Michael R · CIK 0001464583 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:39 UTC |
Moat RossChief Commercial Officer
|
Exercise / conversionRestricted Share Unit · Derivative | 995 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002328 · edgar.xml · derivative · entry 5 Moat Ross · CIK 0001857177 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,982 Underlying: Class A Common Share · 995 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. F4 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021. F4 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:39 UTC |
Moat RossChief Commercial Officer
|
Tax withholdingClass A Common Share | 544 | $10.13 | $5,510.72 |
DisclosureSEC source: 0001179110-22-002328 · edgar.xml · nonDerivative · entry 4 Moat Ross · CIK 0001857177 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,342 Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:39 UTC |
Moat RossChief Commercial Officer
|
Exercise / conversionClass A Common Share | 995 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-002328 · edgar.xml · nonDerivative · entry 3 Moat Ross · CIK 0001857177 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,886 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:38 UTC |
Patel Sanj KDirector · Chairman & CEO
|
Exercise / conversionRestricted Share Unit · Derivative | 6,569 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002326 · edgar.xml · derivative · entry 5 Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,707 Underlying: Class A Common Share · 6,569 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. F2 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021. F2 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:38 UTC |
Patel Sanj KDirector · Chairman & CEO
|
Tax withholdingClass A Common Share | 1,922 | $10.13 | $19,469.86 |
DisclosureSEC source: 0001179110-22-002326 · edgar.xml · nonDerivative · entry 2 Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,647 Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:38 UTC |
Patel Sanj KDirector · Chairman & CEO
|
Exercise / conversionClass A Common Share | 6,569 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-002326 · edgar.xml · nonDerivative · entry 1 Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:39 UTC |
Paolini John F.Chief Medical Officer
|
Exercise / conversionRestricted Share Unit · Derivative | 1,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002327 · edgar.xml · derivative · entry 3 Paolini John F. · CIK 0001741533 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,175 Underlying: Class A Common Share · 1,725 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. F2 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021. F2 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:39 UTC |
Paolini John F.Chief Medical Officer
|
Tax withholdingClass A Common Share | 598 | $10.13 | $6,057.74 |
DisclosureSEC source: 0001179110-22-002327 · edgar.xml · nonDerivative · entry 2 Paolini John F. · CIK 0001741533 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,127 Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:39 UTC |
Paolini John F.Chief Medical Officer
|
Exercise / conversionClass A Common Share | 1,725 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-002327 · edgar.xml · nonDerivative · entry 1 Paolini John F. · CIK 0001741533 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:36 UTC |
Tessari EbenChief Operating Officer
|
Exercise / conversionRestricted Share Unit · Derivative | 1,964 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002324 · edgar.xml · derivative · entry 5 Tessari Eben · CIK 0001867899 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,892 Underlying: Class A Common Share · 1,964 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. F4 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021. F4 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:36 UTC |
Tessari EbenChief Operating Officer
|
Tax withholdingClass A Common Share | 681 | $10.13 | $6,898.53 |
DisclosureSEC source: 0001179110-22-002324 · edgar.xml · nonDerivative · entry 4 Tessari Eben · CIK 0001867899 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,063 Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:36 UTC |
Tessari EbenChief Operating Officer
|
Exercise / conversionClass A Common Share | 1,964 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-002324 · edgar.xml · nonDerivative · entry 3 Tessari Eben · CIK 0001867899 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. Read SEC document |
| January 15, 2022 Filed Mar 18, 2022 20:40 UTC |
Megna Michael RChief Accounting Officer
|
GrantClass A Common Share | 653 | $9.63 | $6,288.39 |
DisclosureSEC source: 0001179110-22-002329 · edgar.xml · nonDerivative · entry 4 Megna Michael R · CIK 0001464583 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,424 F4 · kind: The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of July 16, 2021 to January 15, 2022. The acquisition of such shares was exempt pursuant to Rule 16b-3(c). Read SEC document |
| January 15, 2022 Filed Mar 18, 2022 20:39 UTC |
Moat RossChief Commercial Officer
|
GrantClass A Common Share | 1,546 | $9.63 | $14,887.98 |
DisclosureSEC source: 0001179110-22-002328 · edgar.xml · nonDerivative · entry 2 Moat Ross · CIK 0001857177 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,891 F2 · kind: The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of July 16, 2021 to January 15, 2022. The acquisition of such shares was exempt pursuant to Rule 16b-3(c). Read SEC document |
| January 15, 2022 Filed Mar 18, 2022 20:36 UTC |
Tessari EbenChief Operating Officer
|
GrantClass A Common Share | 970 | $9.63 | $9,341.10 |
DisclosureSEC source: 0001179110-22-002324 · edgar.xml · nonDerivative · entry 2 Tessari Eben · CIK 0001867899 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,780 F2 · kind: The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of July 16, 2021 to January 15, 2022. The acquisition of such shares was exempt pursuant to Rule 16b-3(c). Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 20:51 UTC |
Megna Michael RChief Accounting Officer
|
GrantRestricted Share Units · Derivative | 700 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-009263 · edgar.xml · derivative · entry 1 Megna Michael R · CIK 0001464583 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700 Underlying: Class A Common Shares · 700 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. F2 · derivative.exercise_date: The RSUs vest over a four year period, with 25% of the RSUs vesting on each anniversary of the date of grant, October 4, 2021. F2 · derivative.expiration_date: The RSUs vest over a four year period, with 25% of the RSUs vesting on each anniversary of the date of grant, October 4, 2021. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:18 UTC |
Ragosa MarkChief Financial Officer
|
GrantRestricted Share Units · Derivative | 7,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008653 · edgar.xml · derivative · entry 2 Ragosa Mark · CIK 0001835458 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,444 Underlying: Class A Common Shares · 7,444 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer. F3 · derivative.exercise_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. F3 · derivative.expiration_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:18 UTC |
Ragosa MarkChief Financial Officer
|
GrantShare Option · Derivative | 44,661 | $0.00 Strike: $12.97 | $0.00 |
DisclosureSEC source: 0001179110-21-008653 · edgar.xml · derivative · entry 1 Ragosa Mark · CIK 0001835458 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,661 Underlying: Class A Common Shares · 44,661 shares Expires 2031-09-01 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 2, 2021. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:21 UTC |
Tessari EbenChief Business Officer
|
GrantRestricted Share Units · Derivative | 7,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008660 · edgar.xml · derivative · entry 2 Tessari Eben · CIK 0001867899 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,856 Underlying: Class A Common Shares · 7,856 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer. F3 · derivative.exercise_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. F3 · derivative.expiration_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:21 UTC |
Tessari EbenChief Business Officer
|
GrantShare Option · Derivative | 47,138 | $0.00 Strike: $12.97 | $0.00 |
DisclosureSEC source: 0001179110-21-008660 · edgar.xml · derivative · entry 1 Tessari Eben · CIK 0001867899 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,138 Underlying: Class A Common Shares · 47,138 shares Expires 2031-09-01 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 2, 2021. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:20 UTC |
Megna Michael RChief Accounting Officer
|
GrantRestricted Share Units · Derivative | 3,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008658 · edgar.xml · derivative · entry 2 Megna Michael R · CIK 0001464583 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,098 Underlying: Class A Common Shares · 3,098 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer. F3 · derivative.exercise_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. F3 · derivative.expiration_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:20 UTC |
Megna Michael RChief Accounting Officer
|
GrantShare Option · Derivative | 6,195 | $0.00 Strike: $12.97 | $0.00 |
DisclosureSEC source: 0001179110-21-008658 · edgar.xml · derivative · entry 1 Megna Michael R · CIK 0001464583 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,195 Underlying: Class A Common Shares · 6,195 shares Expires 2031-09-01 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 2, 2021. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:19 UTC |
Pano ArianChief Clinical Dev. Officer
|
GrantRestricted Share Units · Derivative | 3,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008655 · edgar.xml · derivative · entry 2 Pano Arian · CIK 0001867891 · Chief Clinical Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,888 Underlying: Class A Common Shares · 3,888 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer. F3 · derivative.exercise_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. F3 · derivative.expiration_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:19 UTC |
Pano ArianChief Clinical Dev. Officer
|
GrantShare Option · Derivative | 23,325 | $0.00 Strike: $12.97 | $0.00 |
DisclosureSEC source: 0001179110-21-008655 · edgar.xml · derivative · entry 1 Pano Arian · CIK 0001867891 · Chief Clinical Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,325 Underlying: Class A Common Shares · 23,325 shares Expires 2031-09-01 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 2, 2021. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:16 UTC |
Moat RossARCALYST General Manager
|
GrantRestricted Share Units · Derivative | 3,977 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008649 · edgar.xml · derivative · entry 2 Moat Ross · CIK 0001857177 · ARCALYST General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,977 Underlying: Class A Common Shares · 3,977 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer. F3 · derivative.exercise_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. F3 · derivative.expiration_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:16 UTC |
Moat RossARCALYST General Manager
|
GrantShare Option · Derivative | 7,954 | $0.00 Strike: $12.97 | $0.00 |
DisclosureSEC source: 0001179110-21-008649 · edgar.xml · derivative · entry 1 Moat Ross · CIK 0001857177 · ARCALYST General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,954 Underlying: Class A Common Shares · 7,954 shares Expires 2031-09-01 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 2, 2021. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:15 UTC |
Paolini John F.Chief Medical Officer
|
GrantRestricted Share Units · Derivative | 6,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008646 · edgar.xml · derivative · entry 2 Paolini John F. · CIK 0001741533 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,900 Underlying: Class A Common Shares · 6,900 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer. F3 · derivative.exercise_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. F3 · derivative.expiration_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:15 UTC |
Paolini John F.Chief Medical Officer
|
GrantShare Option · Derivative | 41,400 | $0.00 Strike: $12.97 | $0.00 |
DisclosureSEC source: 0001179110-21-008646 · edgar.xml · derivative · entry 1 Paolini John F. · CIK 0001741533 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,400 Underlying: Class A Common Shares · 41,400 shares Expires 2031-09-01 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 2, 2021. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:14 UTC |
Patel Sanj KDirector · Chairman & CEO
|
GrantRestricted Share Units · Derivative | 26,276 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008644 · edgar.xml · derivative · entry 2 Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,276 Underlying: Class A Common Shares · 26,276 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer. F3 · derivative.exercise_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. F3 · derivative.expiration_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:14 UTC |
Patel Sanj KDirector · Chairman & CEO
|
GrantShare Option · Derivative | 157,658 | $0.00 Strike: $12.97 | $0.00 |
DisclosureSEC source: 0001179110-21-008644 · edgar.xml · derivative · entry 1 Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,658 Underlying: Class A Common Shares · 157,658 shares Expires 2031-09-01 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 2, 2021. Read SEC document |
| July 15, 2021 Filed Mar 18, 2022 20:40 UTC |
Megna Michael RChief Accounting Officer
|
GrantClass A Common Share | 588 | $11.49 | $6,756.12 |
DisclosureSEC source: 0001179110-22-002329 · edgar.xml · nonDerivative · entry 3 Megna Michael R · CIK 0001464583 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,771 F3 · kind: The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of January 1, 2021 to July 15, 2021. The acquisition of such shares was exempt pursuant to Rule 16b-3(c). Read SEC document |
| July 15, 2021 Filed Mar 18, 2022 20:39 UTC |
Moat RossChief Commercial Officer
|
GrantClass A Common Share | 963 | $11.49 | $11,064.87 |
DisclosureSEC source: 0001179110-22-002328 · edgar.xml · nonDerivative · entry 1 Moat Ross · CIK 0001857177 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,345 F1 · kind: The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of January 1, 2021 to July 15, 2021. The acquisition of such shares was exempt pursuant to Rule 16b-3(c). Read SEC document |
| July 15, 2021 Filed Mar 18, 2022 20:36 UTC |
Tessari EbenChief Operating Officer
|
GrantClass A Common Share | 868 | $11.49 | $9,973.32 |
DisclosureSEC source: 0001179110-22-002324 · edgar.xml · nonDerivative · entry 1 Tessari Eben · CIK 0001867899 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,810 F1 · kind: The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of January 1, 2021 to July 15, 2021. The acquisition of such shares was exempt pursuant to Rule 16b-3(c). Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 20:22 UTC |
McCain Tracey LDirector
|
GrantShare Option · Derivative | 33,237 | $0.00 Strike: $14.33 | $0.00 |
DisclosureSEC source: 0001179110-21-007186 · edgar.xml · derivative · entry 1 McCain Tracey L · CIK 0001683600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,237 Underlying: Class A Common Shares · 33,237 shares Expires 2031-06-28 F1 · derivative.exercise_date: The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 29, 2021. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 20:22 UTC |
Popovits Kimberly JDirector
|
GrantShare Option · Derivative | 33,237 | $0.00 Strike: $14.33 | $0.00 |
DisclosureSEC source: 0001179110-21-007185 · edgar.xml · derivative · entry 1 Popovits Kimberly J · CIK 0001333482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,237 Underlying: Class A Common Shares · 33,237 shares Expires 2031-06-28 F1 · derivative.exercise_date: The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 29, 2021. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 20:21 UTC |
Malley ThomasDirector
|
GrantShare Option · Derivative | 33,237 | $0.00 Strike: $14.33 | $0.00 |
DisclosureSEC source: 0001179110-21-007184 · edgar.xml · derivative · entry 1 Malley Thomas · CIK 0001403322 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,237 Underlying: Class A Common Shares · 33,237 shares Expires 2031-06-28 F1 · derivative.exercise_date: The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 29, 2021. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 20:20 UTC |
Quart Barry DDirector
|
GrantShare Option · Derivative | 33,237 | $0.00 Strike: $14.33 | $0.00 |
DisclosureSEC source: 0001179110-21-007183 · edgar.xml · derivative · entry 1 Quart Barry D · CIK 0001384243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,237 Underlying: Class A Common Shares · 33,237 shares Expires 2031-06-28 F1 · derivative.exercise_date: The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 29, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.